Akzo Nobel Articles
Akzo Nobel expecting to post record results for 2000
11 January 2001
Akzo sells Chefaro to Belgium's Omega
18 December 2000
Stock Commentary - Europe
16 November 2000
Akzo Nobel to sell Chefaro unit for $88.9 million to Omega?
1 November 2000
Pharmaceutical sales continue to drive growth at Akzo Nobel
25 October 2000
Akzo Nobel investing in pharma R&D sites
6 October 2000
Brazil to implement patent extensions?
11 September 2000
Akzo Nobel set to sell off Chefaro
23 August 2000
Pharma sales up 39% at Akzo Nobel
28 July 2000
Stock Commentary Europe
15 June 2000
Akzo Nobel appointment
11 May 2000
Akzo Nobel net income jumps 30%
26 April 2000
Stock Commentary Europe
19 April 2000
Puregon pen approved by EMEA
2 March 2000
Akzo Nobel to rely on organic growth in niche markets
28 February 2000
Appointment at Akzo Nobel
10 February 2000
Stock Commentary Europe
27 January 2000
Stock Commentary Europe
20 January 2000
Stock Commentary Europe
9 December 1999
Akzo Nobel to build MCA plant in China
3 December 1999
Stock Commentary Europe
4 November 1999
Akzo results driven by pharma growth
27 October 1999
Stock Commentary Europe
12 August 1999
EU appro for Hoechst/Rhone Poulenc deal, but with conditions
11 August 1999
Stock Commentary Europe
5 August 1999
Akzo Nobel posts solid results for second qtr
29 July 1999
Sankyo set to sell stake in Organon
6 July 1999
Stock Commentary Europe
24 June 1999
Puregon Solution approved by EMEA
28 April 1999
Healthy pharma sales for Akzo Nobel
23 April 1999
Stock Commentary Europe
22 April 1999
Organon Teknika licenses analgesic
15 April 1999
Stock Commentary Europe
4 March 1999
Pharmaceuticals "star performer" for Akzo
23 February 1999
Stock Commentary Europe
4 February 1999
Organon to acquire ethical drugs business of Kanebo
4 February 1999
Akzo Nobel Expands Scottish R&D Unit
15 December 1998
Diosynth's Oss Pharma Production Unit Given FDA Approval
9 December 1998
Lehman Report On European Drugmakers' Earnings Predictability
6 November 1998
Akzo Nobel launchs Eurobond
5 November 1998
Akzo Nobel Pharma Sales Slowdown
30 October 1998
PMS Compound Enters Trials
21 October 1998
Stock Commentary Europe
8 October 1998
EU "Has Warned GW Over Pricing In Spain"
5 October 1998
AHP/Monsanto Merger Gets EU Approval
1 October 1998
Stock Commentary Europe
24 September 1998
Headwinds And Hurricanes In European Chem/Pharma Sector
23 September 1998
Stock Commentary Europe
17 September 1998
Stock Commentary Europe
30 July 1998
Akzo Nobel Reports Disappointing 2nd Qtr
30 July 1998
Remeron Outperforms SSRIs In Trials
22 July 1998
Akzo Nobel To Invest In New Pharma Plant
9 July 1998
Stock Commentary Europe
9 July 1998
Merck, Pfizer Lead Charge Up Global Rankings
7 July 1998
Akzo Nobel Looking To US Growth
16 June 1998
R&D To Drive Growth, Says Akzo CEO
28 May 1998
Clinical Trial News In Brief
28 May 1998
Management Changes At Akzo Nobel
30 April 1998
Net Income Up 21% At Akzo Nobel
24 April 1998
Appointment At Akzo-Nobel
26 March 1998
Organon Project To Seek Genetic Basis For CNS Diseases
20 March 1998
European Stock Comment
12 March 1998
Stock Commentary Europe
5 March 1998
Buoyant Results For Akzo Nobel, Says Broker
3 March 1998
Stock Commentary Europe
26 February 1998
Akzo Nobel Posts Strong Earnings Growth
24 February 1998
Male Hormone Replacement Can Cut Osteoporosis
19 February 1998
Consolidation In European Pharma
17 February 1998
Akzo Nobel Workers To Strike Over Pay ?
9 February 1998
DuPont Merck, Signal Sign HIV Deal
16 January 1998
Akzo Nobel Looks For Further Growth In '98
12 January 1998
Court Reverses Pill Ruling In Germany
29 December 1998
EFPIA Expands Membership To Drugmakers
24 November 1997
Stock Commentary Europe
13 November 1997
High 3rd Qtr Net Income For Akzo
4 November 1997
Akzo Nobel Staff Sick Fund Approved
20 October 1997
FDA Clears rFSH Products From Serono, Akzo Nobel
9 October 1997
Growing Foreign Presence In China's Pharma Industry
22 September 1997
Akzo Nobel Invests $25m In Scottish Plant
17 September 1997
Good 2nd Qtr Pharma Performance At Akzo Nobel
7 August 1997
Pherin And Organon Sign Pheromone Drug Deal
24 July 1997
Management Changes at Akzo Nobel
5 May 1997
Net Income Up 2.4% At Akzo Nobel
5 May 1997
European And London Stock Comment
5 May 1997
EU States "Must Own Mutual Recognition"
24 April 1997
Stock Comment Europe
20 March 1997
Second Akzo Nobel Share Offer Completed
17 March 1997
Appointments At Akzo Nobel
10 March 1997
Akzo Nobel's Puregon Available In Holland
27 January 1997
Appointment And Retirement At Akzo Nobel
20 January 1997
1996: A Stop-Go Year For Akzo Nobel
20 January 1997
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
